Key Stats for Vertex Pharmaceuticals Stock

• Past-Week Performance: +4%
• 52-Week Range: $362.5 to $619.7
• Current Price: $474.3

Most investors never know if a stock is truly undervalued or overpriced. TIKR’s professional-grade valuation tools give you a clear, data-backed answer across 60,000+ stocks for free →

What Happened?

Vertex Pharmaceuticals stock (VRTX) trades at $474.27 after a 2.4% pullback, yet 77,000 CF patients on therapy and $12.3 billion in cash signal a company running far ahead of its stock price.

Multiple Vertex executives, including EVP and Chief Commercial Officer Duncan McKechnie and Chief Legal Officer Jonathan Biller, disposed of common shares between February 18 and March 2, while the…